Biomarkers of microvascular function, circulating cells and endothelial integrity in kidney transplant recipients on belatacept or CNI

Completed

• Conditions: Cardiovascular disease; 10011082; 10012653; 10003216

• Registration Number: NL-OMON42067
• Lead Sponsor: ierziekten

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 25

Inclusion Criteria

Participance in IM-103-116.

Exclusion Criteria

None

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Differences in circulating cells (endothelial cells and monocytes), angiogenic<br /><br>and atheroscerotic factors, Micro-RNA's as well as in mean tortuosity index<br /><br>(MTI).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>